A detailed history of Met Life Investment Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 146,416 shares of IOVA stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
146,416
Previous 146,416 -0.0%
Holding current value
$1.2 Million
Previous $1.17 Million 17.04%
% of portfolio
0.01%
Previous 0.01%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.78 - $14.19 $196,911 - $359,148
25,310 Added 20.9%
146,416 $1.17 Million
Q1 2024

May 14, 2024

BUY
$7.59 - $17.47 $919,194 - $2.12 Million
121,106 New
121,106 $1.79 Million
Q3 2023

May 09, 2024

BUY
$4.44 - $8.79 $188,855 - $373,882
42,535 Added 54.14%
121,106 $551,000
Q3 2023

Apr 29, 2024

BUY
$4.44 - $8.79 $50,571 - $100,118
11,390 Added 10.38%
121,106 $551,000
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $50,571 - $100,118
11,390 Added 10.38%
121,106 $551,000
Q2 2023

Apr 29, 2024

BUY
$5.36 - $9.06 $588,077 - $994,026
109,716 New
109,716 $772,000
Q2 2023

Aug 10, 2023

BUY
$5.36 - $9.06 $588,077 - $994,026
109,716 New
109,716 $772,000
Q1 2023

May 09, 2024

BUY
$5.53 - $8.22 $434,497 - $645,853
78,571 New
78,571 $480 Million
Q4 2022

Jun 14, 2023

BUY
$5.62 - $10.0 $441,569 - $785,710
78,571 New
78,571 $502,000
Q3 2022

Jun 14, 2023

BUY
$9.53 - $13.11 $748,781 - $1.03 Million
78,571 New
78,571 $752,000
Q2 2022

May 10, 2024

BUY
$6.38 - $18.33 $469,351 - $1.35 Million
73,566 Added 1469.85%
78,571 $867,000
Q2 2022

Jun 20, 2023

BUY
$6.38 - $18.33 $501,282 - $1.44 Million
78,571 New
78,571 $867,000
Q2 2022

Mar 22, 2023

BUY
$6.38 - $18.33 $469,351 - $1.35 Million
73,566 Added 1469.85%
78,571 $867,000
Q2 2022

Aug 11, 2022

BUY
$6.38 - $18.33 $469,351 - $1.35 Million
73,566 Added 1469.85%
78,571 $867,000
Q1 2022

May 10, 2024

BUY
$12.38 - $19.1 $61,961 - $95,595
5,005 New
5,005 $83,000
Q1 2022

Jun 20, 2023

BUY
$12.38 - $19.1 $61,961 - $95,595
5,005 New
5,005 $83,000
Q1 2022

Mar 22, 2023

BUY
$12.38 - $19.1 $36,731 - $56,669
2,967 Added 145.58%
5,005 $83,000
Q1 2022

May 12, 2022

BUY
$12.38 - $19.1 $61,961 - $95,595
5,005 New
5,005 $83,000
Q4 2021

Feb 15, 2022

SELL
$16.55 - $27.63 $33,728 - $56,309
-2,038 Closed
0 $0
Q3 2021

Mar 22, 2023

SELL
$20.35 - $26.63 $958,383 - $1.25 Million
-47,095 Reduced 95.85%
2,038 $50,000
Q3 2021

Nov 15, 2021

BUY
$20.35 - $26.63 $41,473 - $54,271
2,038 New
2,038 $50,000
Q2 2020

Aug 14, 2020

SELL
$27.21 - $41.0 $1.34 Million - $2.01 Million
-49,133 Closed
0 $0
Q1 2020

Jul 12, 2023

BUY
$19.54 - $38.85 $960,058 - $1.91 Million
49,133 New
49,133 $1.47 Million
Q1 2020

Mar 22, 2023

SELL
$19.54 - $38.85 $48,068 - $95,571
-2,460 Reduced 4.77%
49,133 $1.47 Million
Q1 2020

May 15, 2020

SELL
$19.54 - $38.85 $48,068 - $95,571
-2,460 Reduced 4.77%
49,133 $1.47 Million
Q4 2019

Jul 12, 2023

BUY
$17.95 - $29.41 $926,094 - $1.52 Million
51,593 New
51,593 $1.43 Million
Q3 2019

Jul 12, 2023

BUY
$17.99 - $26.0 $928,158 - $1.34 Million
51,593 New
51,593 $938,000
Q3 2019

Mar 22, 2023

BUY
$17.99 - $26.0 $59,025 - $85,306
3,281 Added 6.79%
51,593 $938,000
Q3 2019

Nov 14, 2019

BUY
$17.99 - $26.0 $59,025 - $85,306
3,281 Added 6.79%
51,593 $939,000
Q2 2019

Jul 12, 2023

BUY
$9.78 - $24.52 $472,491 - $1.18 Million
48,312 New
48,312 $1.18 Million
Q1 2019

Jul 13, 2023

BUY
$8.41 - $11.26 $406,303 - $543,993
48,312 New
48,312 $459,000
Q4 2018

Jul 13, 2023

BUY
$7.51 - $11.93 $362,823 - $576,362
48,312 New
48,312 $427,000
Q4 2018

Mar 22, 2023

SELL
$7.51 - $11.93 $88,850 - $141,143
-11,831 Reduced 19.67%
48,312 $427,000
Q4 2018

Feb 14, 2019

SELL
$7.51 - $11.93 $88,850 - $141,143
-11,831 Reduced 19.67%
48,312 $428,000
Q3 2018

Jul 13, 2023

BUY
$11.25 - $17.7 $436,083 - $686,105
38,763 New
38,763 $436,000
Q3 2018

Mar 22, 2023

SELL
$11.25 - $17.7 $207,315 - $326,175
-18,428 Reduced 23.45%
60,143 $676,000
Q3 2018

Nov 14, 2018

BUY
$11.25 - $17.7 $676,608 - $1.06 Million
60,143 New
60,143 $677,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.29B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.